olaparib,apalutamide
astrazeneca,merck,janssen
['propel', 'presto']
excellent talk by dr johann de bono propel and presto are not practice changing. #esmo22 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists